Previous 10 | Next 10 |
home / stock / mdt / mdt articles
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin de...
Pharmaceutical companies have been at the forefront of artificial intelligence for quite some time. Researchers have been using advanced AI models ...
Apyx Medical (NASDAQ: APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares...
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic (NYSE: MDT). "I like what they’re doing ...
Tuesday, Shockwave Medical Inc (NASDAQ:SWAV) shares traded higher following a Wall Street Journal report suggesting Johnson & Jo...
Wednesday, the FDA approved Medtronic plc’s (NYSE:MDT) Evolut FX+ transcatheter aortic valve replacement (TAVR) system for symptoma...
Medtronic Plc’s (NYSE:MDT) Neurosurgery unit on Thursday said it is recalling the Duet External Drainage and Monitoring System...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Tuesday, Medtronic Plc (NYSE:MDT) reported third-quarter 2024 sales of $8.1 billion, up 4.7% year-on-year (Y/Y) as reported and 4.6% orga...
News, Short Squeeze, Breakout and More Instantly...
For the seventh consecutive year in the U.S., and for the first time in the U.K., Medtronic is recognized as a "Best Place to Work for Disability Inclusion" by Disability:IN and the American Association of People with Disabilities NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For the sevent...
2024-07-16 08:26:00 ET Medtronic (NYSE: MDT) , a beast of a medical-device company, has caught the eye of more than a few income investors. It has enacted dividend raises at least once annually for a hard-to-beat 47 years straight and approaches high-yield dividend territory wit...
2024-07-15 05:44:00 ET The market's been on a bull run, but most of the gains have been confined to a handful of tech stocks at the top. There are still plenty of high-yield dividend stocks that haven't gained as much attention as they probably deserve. Investors looking for near-certai...